Ondansetron orally disintegrating tablet versus placebo for the prevention of postdischarge nausea and vomiting after ambulatory surgery.
Ondansetron orally disintegrating tablet reduces postdischarge nausea and vomiting and improves patient satisfaction with postoperative nausea and vomiting management.
Gan
Tong J
TJ
Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina 27710, USA. gan00001@mc.duke.edu
Franiak
Randall
R
Reeves
Jolin
J
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000556:Ambulatory Surgical Procedures; D000932:Antiemetics / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D017294:Ondansetron / Q000008:administration & dosage / Q000627:therapeutic use*; D020250:Postoperative Nausea and Vomiting / Q000517:prevention & control*; D013607:Tablets
D000932:Antiemetics; D013607:Tablets; D017294:Ondansetron